Phase I trial of in situ vaccination with autologous CCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC.

Authors

null

Aaron Elliott Lisberg

University of California, Los Angeles, Los Angeles, CA

Aaron Elliott Lisberg , Bin Liu , Ramin Salehi-Rad , Jay M. Lee , Linh Tran , Kostyantyn Krysan , Raymond Lim , Camelia Dumitras , Zhe Jiang , Fereidoun Abtin , Scott Genshaft , Gregory Fishbein , Anita Kaul , Kanwarpal Kahlon , Shay Ashouri , Jonathan Wade Goldman , David Elashoff , Edward B. Garon , Steven M. Dubinett , Robert Suh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03546361

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS9135)

DOI

10.1200/JCO.2021.39.15_suppl.TPS9135

Abstract #

TPS9135

Poster Bd #

Online Only

Abstract Disclosures